학력
2008-2012 서울대학교 의과대학, 박사 (약물역학)
2005-2008 서울대학교 보건대학원, 석사 (보건정책)
2000-2005 서울대학교 약학대학, 학사
주요경력
2016-2026 성균관대학교 약학대학 조교수, 부교수, 교수, 바이오헬스 규제과학과 학과장
2015-2016 맥길대학교 박사후연구원
2012-2015 한국의약품안전관리원 DUR정보팀장, 책임연구원
관심연구분야
– 약물역학 및 약물감시
– 규제적 의사결정을 위한 리얼월드데이터 활용
대표논문자료
- Shin, JY; Park, MJ; Lee, SH; Choi, SH; Kim, MH; Choi, NK; Lee, J; Park, BJ. Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study. BMJ 2015; 351:h3517. (IF=43.0, Top 1.4%) (1st author)
- Shin, JY; Roughead, EE; Park, BJ; Pratt, NL. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study. BMJ 2016; 353: j2550. (IF=43.0, Top 1.4%) (1st author)
- Yoon, D; Lee, JH; Lee, H; Shin, JY. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study. BMJ 2021;372:m4931. (IF=43.0, Top 1.4%) (Corresponding author)
- Choi, EY; Cho, Y; Oh, J; Choi, A; Kim, H; Shin, JY. Oral Corticosteroid Use During Pregncy and the Risk of Gestational Diabetes. JAMA Intern Med. 2025. (IF=23.3, Top 2%) (Corresponding author)
- Hong, B; Lee, H; Jung, K; Rhee, SY; Yon, DK; Shin, JY. Sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases: population based cohort study. BMJ 2025;391:e085196. (IF=43.0, Top 1.4%) (Corresponding author)
- Hong, B; Bea, S; Ko, HY; Kim, WJ; Cho, YM; Shin, JY. Sodium-Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia : A Population-Based Cohort Study. Ann Intern Med 2024;177(10):1319-1329. (IF=15.4, Top 2.6%) (Corresponding author)
- Bea, S; Jeong, HE; Park, S; Yu, OHY; Chang, Y; Cho, J; Sinn, DH; Cho, YM; Shin, JY. Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study. Gut 2023;72(5):1020-1022. (IF=26.2, Top 2.4%) (Corresponding author)
- Bea, S; Ko, HY; Bae, JH; Cho, YM; Chang, Y; Ryu, S; Byrne, CD; Shin, JY. Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease. Gut 2025;74(2):284-294. (IF=26.2, Top 2.4%) (Corresponding author)
- Noh, Y; Jeong, HE; Choi, A; Choi, EY; Pasternak, B; Nordeng, H; Bliddal, M; Man, KKC; Wong, ICK; Yon, DK; Shin, JY. Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children. JAMA Pediatr. 2023;177(3):267-277.
